Analysed ARS PHARMACEUTICALS INC (SPRY:NASDAQ) News Sources
ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label
27-03-2026
yahoo.com
ARS Pharmaceuticals Inc (SPRY) Q4 2025 Earnings Call Highlights: Strong Market Entry and ...
09-03-2026
yahoo.com
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization
09-03-2026
yahoo.com
ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
02-03-2026
yahoo.com
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences
23-02-2026
yahoo.com
How Recent Regulatory Twists Are Reframing The Story For ARS Pharmaceuticals (SPRY)
18-02-2026
yahoo.com
What is the current price of ARS PHARMACEUTICALS INC (SPRY:NASDAQ)?
The current price of ARS PHARMACEUTICALS INC (SPRY:NASDAQ) is $8.05.
ARS PHARMACEUTICALS INC (SPRY:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARS PHARMACEUTICALS INC (SPRY:NASDAQ) since the previous trading day is $-0.22.
ARS PHARMACEUTICALS INC (SPRY:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARS PHARMACEUTICALS INC (SPRY:NASDAQ) since the previous trading day is -2.6602%.
What is the most recent average sentiment score for ARS PHARMACEUTICALS INC (SPRY:NASDAQ)?
The most recent average sentiment score for ARS PHARMACEUTICALS INC (SPRY:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for ARS PHARMACEUTICALS INC (SPRY:NASDAQ)?
The most recent sentiment for ARS PHARMACEUTICALS INC (SPRY:NASDAQ) is .
SEC-8K** Filing Available For ARS PHARMACEUTICALS INC (SPRY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.